Karen Foster Biography and Net Worth

Insider of BioLife Solutions

Karen Foster has been chief quality officer at BioLife since December 2019. She joined the company as Vice President of Operations in April 2016. From 2003 to early 2016, Karen was Vice President of Laboratory Operations and Site Leader at ViaCord, LLC, a family cord blood bank, and subsidiary of PerkinElmer Inc.

Karen has managed manufacturing and quality operations in several capacities over the course of her 25-year career, for such companies as Pfizer, Inc. (formerly Pharmacia Corporation) and Amersham Pharmacia Biotech, Inc. (formerly Pharmacia Biotech, Inc.)

She has two degrees from the University of Wisconsin, Milwaukee: an MBA specializing in Operations Management, and an MS in Zoology. She earned her B.S. in Biological Sciences from Michigan Technological University.

What is Karen A. Foster's net worth?: The estimated net worth of Karen A. Foster is at least $3.93 million as of November 12th, 2024. Ms. Foster owns 157,225 shares of BioLife Solutions stock worth more than $3,932,197 as of November 21st. This net worth approximation does not reflect any other assets that Ms. Foster may own. Additionally, Ms. Foster receives an annual salary of $395,200.00 as Insider at BioLife Solutions. Learn More about Karen A. Foster's net worth.
How old is Karen A. Foster?: Ms. Foster is currently 64 years old. There are 5 older executives and no younger executives at BioLife Solutions. Learn More on Karen A. Foster's age.
What is Karen A. Foster's salary?: As the Insider of BioLife Solutions, Inc., Ms. Foster earns $395,200.00 per year. There are 3 executives that earn more than Ms. Foster. The highest earning executive at BioLife Solutions is Mr. Roderick de Greef, CEO & Chairman, who commands a salary of $1,630,000.00 per year. Learn More on Karen A. Foster's salary.
How do I contact Karen A. Foster?: The corporate mailing address for Ms. Foster and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at [email protected]. Learn More on Karen A. Foster's contact information.
Has Karen A. Foster been buying or selling shares of BioLife Solutions?: During the last ninety days, Karen A. Foster has sold $1,738.44 in BioLife Solutions stock. Most recently, Karen A. Foster sold 66 shares of the business's stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $26.34, for a transaction totalling $1,738.44. Following the completion of the sale, the insider now directly owns 157,225 shares of the company's stock, valued at $4,141,306.50. Learn More on Karen A. Foster's trading history.
Who are BioLife Solutions' active insiders?: BioLife Solutions' insider roster includes Sarah Aebersold (VP), Todd Berard (CMO), Roderick de Greef (CFO), Karen Foster (Insider), Andrew Hinson (Director), Aby Mathew (VP), Michael Rice (CEO), Joseph Schick (Director), Marcus Schulz (CRO), and Troy Wichterman (CFO). Learn More on BioLife Solutions' active insiders.
Are insiders buying or selling shares of BioLife Solutions?: In the last twelve months, insiders at the medical equipment provider sold shares 75 times. They sold a total of 136,717 shares worth more than $2,703,077.70. The most recent insider tranaction occured on November, 18th when EVP Aby J Mathew sold 17,604 shares worth more than $352,960.20. Insiders at BioLife Solutions own 2.2% of the company. Learn More about insider trades at BioLife Solutions.
Information on this page was last updated on 11/18/2024.

Karen A. Foster Insider Trading History at BioLife Solutions

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/12/2024	Sell	66	$26.34	$1,738.44	157,225
9/16/2024	Sell	267	$25.12	$6,707.04	157,568
8/21/2024	Sell	96	$25.61	$2,458.56	157,835
7/18/2024	Sell	240	$22.50	$5,400.00	157,931
5/29/2024	Sell	408	$21.78	$8,886.24	158,171
5/17/2024	Sell	85	$22.18	$1,885.30	158,579
3/27/2024	Sell	395	$17.99	$7,106.05	159,145
3/11/2024	Sell	319	$17.42	$5,556.98	164,717
1/19/2024	Sell	1,198	$16.76	$20,078.48	124,027
1/2/2024	Sell	601	$16.75	$10,066.75	125,225
12/1/2023	Sell	466	$12.37	$5,764.42	125,340
11/13/2023	Sell	114	$10.77	$1,227.78	125,539
9/28/2023	Sell	568	$14.16	$8,042.88	124,767
8/25/2023	Sell	410	$10.99	$4,505.90	124,342
8/14/2023	Sell	156	$12.38	$1,931.28	124,752
6/27/2023	Sell	590	$22.91	$13,516.90	124,908
5/31/2023	Sell	392	$23.21	$9,098.32	125,498
5/15/2023	Sell	106	$18.71	$1,983.26	125,890
4/6/2023	Sell	1,101	$20.03	$22,053.03	121,839
3/29/2023	Sell	390	$20.62	$8,041.80	122,940
3/7/2023	Sell	175	$22.95	$4,016.25	123,330
3/1/2023	Sell	1,203	$22.75	$27,368.25	123,505
2/9/2023	Sell	81	$24.60	$1,992.60	124,708
12/28/2022	Sell	605	$16.90	$10,224.50	107,811
11/29/2022	Sell	307	$19.93	$6,118.51	108,416
11/10/2022	Sell	91	$23.16	$2,107.56	108,723
9/29/2022	Sell	559	$23.02	$12,868.18	108,814
8/10/2022	Sell	95	$23.17	$2,201.15	109,394
6/28/2022	Sell	598	$14.86	$8,886.28	108,236
5/27/2022	Sell	174	$14.53	$2,528.22	107,839
5/13/2022	Sell	58	$12.32	$714.56	107,480
4/18/2022	Sell	16,413	$17.59	$288,704.67	107,538
3/29/2022	Sell	547	$22.24	$12,165.28
3/1/2022	Sell	221	$23.78	$5,255.38
2/10/2022	Sell	293	$29.38	$8,608.34
12/29/2021	Sell	625	$39.37	$24,606.25
11/30/2021	Sell	315	$37.59	$11,840.85
11/22/2021	Sell	16,332	$46.19	$754,375.08
10/25/2021	Sell	16,332	$44.45	$725,957.40
10/14/2021	Sell	1,082	$39.97	$43,247.54
9/27/2021	Sell	16,332	$44.66	$729,387.12
8/26/2021	Sell	325	$57.26	$18,609.50	72,452
8/23/2021	Sell	16,332	$46.54	$760,091.28
7/26/2021	Sell	16,333	$45.24	$738,904.92
6/21/2021	Sell	16,332	$42.79	$698,846.28	89,716
5/28/2021	Sell	264	$33.87	$8,941.68	73,384
5/24/2021	Sell	16,332	$31.44	$513,478.08	89,980
4/19/2021	Sell	16,332	$32.58	$532,096.56	89,980
4/1/2021	Sell	3,414	$36.53	$124,713.42	74,208
3/26/2021	Sell	2,562	$35.01	$89,695.62	65,411
3/22/2021	Sell	16,332	$37.56	$613,429.92	84,305
2/26/2021	Sell	284	$39.57	$11,237.88	67,973
2/22/2021	Sell	16,334	$39.66	$647,806.44	84,591
2/19/2021	Sell	3,344	$40.76	$136,301.44	54,899
2/17/2021	Sell	3,281	$41.55	$136,325.55	54,899
12/1/2020	Sell	166	$35.49	$5,891.34	50,742
9/29/2020	Sell	977	$28.63	$27,971.51	50,908
8/26/2020	Sell	179	$20.48	$3,665.92	51,885
5/28/2020	Sell	170	$16.87	$2,867.90	52,064
2/26/2020	Sell	884	$15.02	$13,277.68	23,701

Karen A. Foster Buying and Selling Activity at BioLife Solutions

BioLife Solutions Company Overview

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Today's Range

Now: $25.01

$21.90

$25.11

50 Day Range

MA: $23.96

$20.47

$26.60

2 Week Range

Now: $25.01

$11.91

$28.88

Volume

926,418 shs

Average Volume

385,125 shs

Market Capitalization

$1.16 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Karen Foster Biography and Net Worth

What is Karen A. Foster's net worth?

How old is Karen A. Foster?

What is Karen A. Foster's salary?

How do I contact Karen A. Foster?

Has Karen A. Foster been buying or selling shares of BioLife Solutions?

Who are BioLife Solutions' active insiders?

Are insiders buying or selling shares of BioLife Solutions?